DE2650171A1 - Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel - Google Patents

Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Info

Publication number
DE2650171A1
DE2650171A1 DE19762650171 DE2650171A DE2650171A1 DE 2650171 A1 DE2650171 A1 DE 2650171A1 DE 19762650171 DE19762650171 DE 19762650171 DE 2650171 A DE2650171 A DE 2650171A DE 2650171 A1 DE2650171 A1 DE 2650171A1
Authority
DE
Germany
Prior art keywords
dihydro
stands
anthracene
azolyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762650171
Other languages
German (de)
English (en)
Inventor
Karl-Heinz Prof Dr Buechel
Ingo Dr Haller
Wolfgang Dr Kraemer
Manfred Dr Plempel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE19762650171 priority Critical patent/DE2650171A1/de
Priority to US05/840,461 priority patent/US4183940A/en
Priority to GB44333/77A priority patent/GB1534835A/en
Priority to CH1298677A priority patent/CH629786A5/de
Priority to NL7711830A priority patent/NL7711830A/xx
Priority to IL53243A priority patent/IL53243A0/xx
Priority to FI773209A priority patent/FI773209A/fi
Priority to SE7712111A priority patent/SE7712111L/xx
Priority to ES463647A priority patent/ES463647A1/es
Priority to DK480377A priority patent/DK480377A/da
Priority to AT773277A priority patent/ATA773277A/de
Priority to BE182160A priority patent/BE860249A/xx
Priority to FR7732559A priority patent/FR2369278A1/fr
Priority to JP12881577A priority patent/JPS5356666A/ja
Publication of DE2650171A1 publication Critical patent/DE2650171A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19762650171 1976-10-30 1976-10-30 Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel Withdrawn DE2650171A1 (de)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DE19762650171 DE2650171A1 (de) 1976-10-30 1976-10-30 Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US05/840,461 US4183940A (en) 1976-10-30 1977-10-07 Antimycotic imidazolyl-9,10-dihydro-anthracene derivatives
GB44333/77A GB1534835A (en) 1976-10-30 1977-10-25 Azolyl-9,10-dihydro-anthracene derivatives process for their preparation and their use as medicaments
CH1298677A CH629786A5 (de) 1976-10-30 1977-10-25 Verfahren zur herstellung von neuen azolyl-9,10-dihydro-anthracen-derivaten.
NL7711830A NL7711830A (nl) 1976-10-30 1977-10-27 Azolyl-9.10-dihydro-antraceenderivaten, werk- wijzen ter bereiding ervan en hun toepassing als geneesmiddelen.
IL53243A IL53243A0 (en) 1976-10-30 1977-10-27 Azolyl-9,10-dihydro-anthracene derivatives their preparation and pharmaceutical compositions containing them
FI773209A FI773209A (fi) 1976-10-30 1977-10-27 Azolyl-9,10-dihydro-antracen-derivat foerfarande foer deras framstaellning och deras anvaendning som laekemedel
SE7712111A SE7712111L (sv) 1976-10-30 1977-10-27 Azolyl-9,10-dihydro-antracen-derivat, sett for framstellning och anvendning derav som lekemedel
ES463647A ES463647A1 (es) 1976-10-30 1977-10-28 Procedimiento para preparar derivados de azolil-9,10-dihi- droantraceno.
DK480377A DK480377A (da) 1976-10-30 1977-10-28 Fremgangsmaade til fremstilling af azolyl-9,10-dihydrianthracen-derivater
AT773277A ATA773277A (de) 1976-10-30 1977-10-28 Verfahren zur herstellung von neuen azolyl-9,10 -dihydroanthracen-derivaten und deren salzen
BE182160A BE860249A (fr) 1976-10-30 1977-10-28 Nouveaux derives azolyl-9,10-dihydro-anthraceniques leur procede de preparation et medicament les contenant
FR7732559A FR2369278A1 (fr) 1976-10-30 1977-10-28 Nouveaux
JP12881577A JPS5356666A (en) 1976-10-30 1977-10-28 Azolyll9*100dihydrooanthracene derivative preparation method uses as medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762650171 DE2650171A1 (de) 1976-10-30 1976-10-30 Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DE2650171A1 true DE2650171A1 (de) 1978-05-11

Family

ID=5992241

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762650171 Withdrawn DE2650171A1 (de) 1976-10-30 1976-10-30 Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Country Status (14)

Country Link
US (1) US4183940A (US20040025266A1-20040212-C00001.png)
JP (1) JPS5356666A (US20040025266A1-20040212-C00001.png)
AT (1) ATA773277A (US20040025266A1-20040212-C00001.png)
BE (1) BE860249A (US20040025266A1-20040212-C00001.png)
CH (1) CH629786A5 (US20040025266A1-20040212-C00001.png)
DE (1) DE2650171A1 (US20040025266A1-20040212-C00001.png)
DK (1) DK480377A (US20040025266A1-20040212-C00001.png)
ES (1) ES463647A1 (US20040025266A1-20040212-C00001.png)
FI (1) FI773209A (US20040025266A1-20040212-C00001.png)
FR (1) FR2369278A1 (US20040025266A1-20040212-C00001.png)
GB (1) GB1534835A (US20040025266A1-20040212-C00001.png)
IL (1) IL53243A0 (US20040025266A1-20040212-C00001.png)
NL (1) NL7711830A (US20040025266A1-20040212-C00001.png)
SE (1) SE7712111L (US20040025266A1-20040212-C00001.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121081B1 (de) * 1983-03-03 1991-01-30 BASF Aktiengesellschaft Azolylmethylcycloalkane, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531518A (de) * 1968-11-29 1972-12-15 Bayer Ag Verfahren zur Herstellung von N-substituierten Imidazolen und deren Salzen
US3764609A (en) * 1970-06-22 1973-10-09 Koninklijke Pharma Fab Nv 1 (dibenzo {8 4,d{9 {0 cyclohepten-5-yl), 1-(dibenzo {8 a,d{9 {0 cycloheptan-5-yl) and 1-(dibenzo {8 a,d{9 {0 cyclooctanyl)imidazoles
US3821394A (en) * 1970-07-29 1974-06-28 H Timmler Antimycotic composition and method employing a substituted benzyl-azoles
DE2053080C3 (de) * 1970-10-29 1979-08-23 Bayer Ag N-substituierte Imidazole und ihre Verwendung als Arzneimittel
DE2448060A1 (de) * 1974-10-09 1976-04-15 Bayer Ag Mittel zur regulierung des pflanzenwachstums

Also Published As

Publication number Publication date
GB1534835A (en) 1978-12-06
CH629786A5 (de) 1982-05-14
NL7711830A (nl) 1978-05-03
JPS5356666A (en) 1978-05-23
US4183940A (en) 1980-01-15
ATA773277A (de) 1979-09-15
FI773209A (fi) 1978-05-01
FR2369278B1 (US20040025266A1-20040212-C00001.png) 1980-06-13
DK480377A (da) 1978-05-01
FR2369278A1 (fr) 1978-05-26
BE860249A (fr) 1978-04-28
IL53243A0 (en) 1977-12-30
ES463647A1 (es) 1978-07-16
SE7712111L (sv) 1978-05-01

Similar Documents

Publication Publication Date Title
EP0011769B1 (de) Hydroxyethyl-azole, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
EP0011768A1 (de) Hydroxypropyl-triazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0005250B1 (de) Hydroxypropyl-imidazole, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP0003796B1 (de) Substituierte Diphenyl-imidazolyl-methane, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE3204795A1 (de) Azolyl-phenoxy-tetrahydrofuran-2-yliden-methane, verfahren zu ihrer herstellung sowie antimikrobielle mittel, die diese stoffe enthalten
DE2324424A1 (de) Antimikrobielle mittel
EP0023614A1 (de) Antimykotische Mittel, die Imidazolylenolether umfassen, ihre Herstellung und ihre Verwendung
EP0011770B1 (de) Fluorenyl-azolylmethyl-carbinole, Verfahren zu ihrer Herstellung, Arzneimittel, die diese Verbindungen enthalten und Verfahren zur Herstellung dieser Arzneimittel
DE3228870A1 (de) Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
EP0022969B1 (de) Antimykotische Mittel, die Azolyl-alkenole enthalten und ihre Herstellung
EP0037049A1 (de) Biphenylyl-imidazolylethan-Derivate, Verfahren zu ihrer Herstellung und diese Verbindingungen enthaltende Arzneimittel
DE2650171A1 (de) Azolyl-9,10-dihydro-anthracen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2824690A1 (de) Substituierte imidazolyl-thiazolyl- methane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2705677A1 (de) 2,4-dichlorphenyl-imidazolyl-aethanone(ole), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2832677A1 (de) Hydroxypropyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0039814B1 (de) Imidazolyl-indeno-thiophene, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE3019028A1 (de) Antimikrobielle mittel
EP0019730B1 (de) Antimykotisches Mittel, Verfahren zur Herstellung dieses Mittels
DE2820489A1 (de) Hydroxypropyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2742175A1 (de) Antimikrobielle mittel
EP0031883A1 (de) Antimikrobielle Mittel enthaltend Hydroxybutylimidazol-Derivate
DE2847050A1 (de) Antimikrobielle mittel
DE2635664A1 (de) Antimikrobielle mittel
DE2229128A1 (de) Disubstituierte tritylimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3033918A1 (de) Substituierte 2,4-dichlorphenyl-imidazol-vinyl-ketone, verfahren zu ihrer herstellung sowie antimikrobielle mittel, die diese stoffe enthalten

Legal Events

Date Code Title Description
8130 Withdrawal